HQH Logo

Tekla Healthcare Investors (HQH) 

NYSE$16.5599+0.05 (0.30%)
Market Cap
$798.28M
Sector
Financial Services
Industry
Asset Management
Rank in Sector
287 of 637
Rank in Industry
50 of 101

HQH Insider Trading Activity

HQH Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$27,5022100
Sells
$000

Related Transactions

DiMartino Rosedirector1$18,8800$0$18,880
Goetz Kathleendirector1$8,6220$0$8,622

About Tekla Healthcare Investors

Tekla Healthcare Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as current or anticipated market position for services or products, experienced business management, recognized technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotechnology Index, the S&P 500 Index, and the S&P 1500 Healthcare Index. It was previously known as H&Q Healthcare Investors. Tekla Healthcare Investors was formed on October 31, 1986 and is domiciled in the United States.

Insider Activity of Tekla Healthcare Investors

Over the last 12 months, insiders at Tekla Healthcare Investors have bought $27,502 and sold $0 worth of Tekla Healthcare Investors stock.

On average, over the past 5 years, insiders at Tekla Healthcare Investors have bought $175,291 and sold $0 worth of stock each year.

Highest buying activity among insiders over the last 12 months: DiMartino Rose (director) — $18,880. Goetz Kathleen (director) — $8,622.

The last purchase of 1,000 shares for transaction amount of $18,880 was made by DiMartino Rose (director) on 2024‑07‑16.

List of Insider Buy and Sell Transactions, Tekla Healthcare Investors

2024-07-16PurchaseDiMartino Rosedirector
1,000
0.0022%
$18.88$18,880-0.40%
2024-04-09PurchaseGoetz Kathleendirector
525
0.001%
$16.42$8,622+16.58%
2024-01-02PurchaseReit Todddirector
1,000
0.002%
$16.93$16,929+9.89%
2023-12-28PurchaseMaher Billdirector
1,000
0.002%
$16.58$16,580+12.11%
2023-12-21PurchaseGoodson Alan RVice President
170
0.0003%
$16.13$2,742+13.77%
2023-09-25PurchaseOMSTEAD DANIEL RPresident
9,500
0.0176%
$15.63$148,515+13.65%
2023-09-20PurchaseOMSTEAD DANIEL RPresident
9,500
0.0179%
$15.88$150,829+12.56%
2022-03-23PurchaseGoetz Kathleen
73.53
0.0002%
$20.42$1,501-2.44%
2022-01-26PurchaseGoetz Kathleendirector
481
0.0012%
$21.52$10,349-4.38%
2020-10-26PurchaseOMSTEAD DANIEL RPresident
5,200
0.0127%
$20.53$106,744+25.96%
2020-10-21PurchaseOMSTEAD DANIEL RPresident
5,050
0.0124%
$20.68$104,427+26.31%
2020-09-23PurchaseBailey Jeffrey Allendirector
490
0.0012%
$20.39$9,991+26.68%
2020-05-21PurchaseOMSTEAD DANIEL RPresident
5,000
0.0125%
$21.01$105,054+8.26%
2020-03-17PurchaseOMSTEAD DANIEL RPresident
6,800
0.0131%
$16.24$110,412+35.42%
2018-12-26PurchaseOMSTEAD DANIEL RPresident
6,300
0.0128%
$17.14$107,971+16.80%
2018-10-25PurchaseOMSTEAD DANIEL RPresident
5,500
0.0133%
$20.43$112,344+2.40%
2018-10-17PurchaseOMSTEAD DANIEL RPresident
3,882
0.01%
$21.78$84,534-4.72%
2018-01-25PurchaseKent Thomas Mdirector
1,100
0.0032%
$24.19$26,605-7.29%
2016-01-06PurchaseGasperoni Timothy L
862
0.003%
$28.98$24,978-12.40%
2015-06-29PurchaseSTEBBINS LUCINDA Hdirector
2,000
0.0085%
$35.74$71,480-14.20%
Total: 38
*Gray background shows transactions not older than one year

Insider Historical Profitability

9.94%
Goetz Kathleendirector
1080
0.0022%
$17,823.0230<0.0001%
DiMartino Rosedirector
1000
0.0021%
$16,510.0010
OMSTEAD DANIEL RPresident
178269
0.3687%
$2.94M190+13.57%
STEBBINS LUCINDA Hdirector
6513
0.0135%
$107,530.9740+0.99%
LEWIN LAWRENCE Sdirector
4359
0.009%
$71,961.1510+7.55%
MACK ROBERT Pdirector
3910
0.0081%
$64,549.5910+6.64%
Kent Thomas Mdirector
1100
0.0023%
$18,161.0010<0.0001%
Maher Billdirector
1000
0.0021%
$16,510.0010+12.11%
Reit Todddirector
1000
0.0021%
$16,510.0010+9.89%
Gasperoni Timothy L
862
0.0018%
$14,231.6210<0.0001%
REARDON WILLIAM Sdirector
646
0.0013%
$10,665.4610+15.37%
BONNEY MICHAEL Wdirector
650
0.0013%
$10,731.5010+15.37%
Bailey Jeffrey Allendirector
490
0.001%
$8,089.9010+26.68%
POHOTSKY OLEG Mdirector
200
0.0004%
$3,302.0010+15.09%
Goodson Alan RVice President
170
0.0004%
$2,806.7010+13.77%
*Gray background shows insiders who have made transactions during last year

Historical Insider Profitability vs. Competitors

$23,777,956
244
4.99%
$1.2B
$81,434,647
226
8.61%
$1.2B
$51,393,680
191
4.08%
$765.46M
$11,451,183
137
8.40%
$1.14B
$65,907,882
117
13.29%
$932.34M
$8,121,707
113
7.88%
$502.09M
$4,260,367
95
4.30%
$620.1M
$20,502,573
94
14.44%
$519.48M
$5,304,044
86
11.86%
$673.81M
$7,647,981
80
13.21%
$999.18M
$29,898,201
63
14.61%
$687.53M
$3,606,814
57
-2.58%
$1.09B
$8,137,807
51
10.22%
$1.02B
$3,053,175
47
12.53%
$849.96M
$1,732,067
45
8.35%
$582.76M
$1,528,008
44
11.99%
$705.76M
Tekla Healthcare Investors
(HQH)
$1,743,968
36
9.94%
$798.28M
$29,554,520
21
-5.74%
$658.95M
$30,000,003
1
3.62%
$893.15M

HQH Institutional Investors: Active Positions

Increased Positions66+51.97%2M+18.32%
Decreased Positions48-37.8%2M-15%
New Positions26New1MNew
Sold Out Positions22Sold Out285,561Sold Out
Total Postitions145+14.17%13M+3.32%

HQH Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Morgan Stanley$53,804.006.7%3.22M-128,246-3.83%2024-12-31
Saba Capital Management, L.P.$32,966.004.11%1.97M-900,303-31.35%2024-12-31
Raymond James Financial Inc$15,678.001.95%937,656+937,656New2024-12-31
Penserra Capital Management Llc$15,546.001.94%929,755+62,626+7.22%2024-12-31
Raymond James Financial Services Advisors, Inc.$7,271.000.91%434,856+176,667+68.42%2024-09-30
Royal Bank Of Canada$7,263.000.91%434,385+3,876+0.9%2024-12-31
Raymond James & Associates$5,939.000.74%355,205+157,618+79.77%2024-09-30
Ameriprise Financial Inc$4,809.000.6%287,607+27,043+10.38%2024-12-31
Lpl Financial Llc$4,715.000.59%282,020+111,383+65.28%2024-12-31
Needham Investment Management Llc$4,265.000.53%255,07800%2024-12-31

Financial Ratios

Summary
Comparison with Competitors

Analyst Recommendations

Analyst Price Targets

No data is available at this moment.
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.